Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -72.97 is 9939% below its 5-year average of 0.74, near the low end of its 5-year range (-72.97–3.92).
As of the fiscal period ended Tuesday, June 30, 2026. 434.35% below its 12-month average of -13.66.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -72.97.
DEBT TO EQUITY RATIO
-72.97
DEBT TO EQUITY RATIO AVG TTM
-13.66
DEBT TO EQUITY RATIO AVG 3Y
1.26
DEBT TO EQUITY RATIO AVG 5Y
0.74
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-434.35%
CURRENT VS 3Y AVG
-5872.68%
CURRENT VS 5Y AVG
-9939.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 749 covered companies
CURRENT VS SECTOR MEDIAN
-66440.78%
vs the sector median at left
Mirum Pharmaceuticals, Inc.
Market Cap
$4.81B
Debt to Equity Ratio
-72.97
TTM Avg
-13.66
3Y Avg
1.26
5Y Avg
0.74
Market Cap
$4.79B
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$4.72B
Debt to Equity Ratio
0.27
TTM Avg
0.44
3Y Avg
1.89
5Y Avg
1.89
Market Cap
$4.70B
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$4.67B
Debt to Equity Ratio
0.14
TTM Avg
0.24
3Y Avg
0.29
5Y Avg
0.27
Market Cap
$4.66B
Debt to Equity Ratio
1.01
TTM Avg
0.92
3Y Avg
0.87
5Y Avg
0.94
Market Cap
$4.65B
Debt to Equity Ratio
0.04
TTM Avg
0.04
3Y Avg
0.07
5Y Avg
0.05
Market Cap
$5.06B
Debt to Equity Ratio
0.49
TTM Avg
0.57
3Y Avg
0.53
5Y Avg
0.48
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.81B | -72.97 | -13.66 | 1.26 | 0.74 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.79B | 0.00 | 0.00 | 0.01 | 0.01 |
| BillionToOne, Inc. (BLLN)vs › | $4.72B | 0.27 | 0.44 | 1.89 | 1.89 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.70B | 0.00 | 0.00 | 0.00 | 0.00 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.67B | 0.14 | 0.24 | 0.29 | 0.27 |
| Erasca, Inc. (ERAS)vs › | $4.96B | 0.12 | 0.13 | 0.14 | 0.11 |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 1.01 | 0.92 | 0.87 | 0.94 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.65B | 0.04 | 0.04 | 0.07 | 0.05 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 0.49 | 0.57 | 0.53 | 0.48 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.06B | 0.80 | 0.31 | 0.29 | 0.31 |
Debt/Equity
-72.97
Current Ratio
2.86
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -72.97 |
| 2026-03-31 | 1.34 |
| 2025-12-31 | 1.02 |
| 2025-09-30 | 1.09 |
| 2025-06-30 | 1.25 |
| 2025-03-31 | 1.36 |
| 2024-12-31 | 1.41 |
| 2024-09-30 | 1.37 |
| 2024-06-30 | 1.38 |
| 2024-03-31 | 1.31 |
| 2023-12-31 | 1.24 |
| 2023-09-30 | 1.14 |
| 2023-06-30 | 3.92 |
| 2023-03-31 | 0.01 |
| 2022-12-31 | 0.02 |
| 2022-09-30 | 0.01 |
| 2022-06-30 | 0.02 |
| 2022-03-31 | 0.02 |
| 2021-12-31 | 0.02 |
| 2021-09-30 | 0.05 |
| 2021-06-30 | 0.03 |
| 2021-03-31 | 0.02 |
| 2020-12-31 | 0.02 |
| 2020-09-30 | 0.03 |
| 2020-06-30 | 0.03 |
| 2020-03-31 | 0.02 |
| 2019-12-31 | 0.03 |
| 2019-09-30 | 0.02 |
| 2019-06-30 | -0.10 |
| 2019-03-31 | -0.08 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
